Jun 14, 2021 / 12:00PM GMT
Operator
Greetings. Welcome to Gracell Biotechnologies Clinical Update Conference Call. (Operator Instructions) Please note that this conference is being recorded. At this time, I'll turn the conference over to Kevin Xie, Chief Financial Officer. Kevin, you may now begin.
Yili Xie - Gracell Biotechnologies Inc. - CFO
Good morning, and welcome to Gracell's Clinical Update Conference Call and the Webcast. There is a slide presentation accompanying today's call. This slide presentation can be accessed on the Investor Relations section of retail website at gracellbio.com. I would also like to remind you that this call is being recorded for replay. Please note that for certain information discussed on the call today, including clinical data and future plans of our programs with our management will be making forward-looking statements. Actual results could differ materially from those stated or implied by these forward-looking statements as a result of various important factors. And please refer to the Risk Factors section of our latest 20-F filing with SEC for a full
Gracell Biotechnologies Inc Clinical Update Conference Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot